In the case of the ABC population, transcriptome analysis indicated higher expression of ITGAX or CD11c in high-CAD-severity patients, while higher expression of CD72, a negative regulator of BCR signaling, was found in CAD patients with low severity (Figure 6D). The gene discussed is CD72; the disease is aneurysmal bone cyst.